Press Releases
PreEvnt’s isaac® Advances to Clinical Trials
Oxnard, Calif (November 18, 2025) – PreEvnt today announced that its non-invasive glucose monitoring system, isaac®, has entered clinical trials at Indiana University Indianapolis under the direction of Dr. Mangilal Agarwal.
Introducing isaac by PreEvnt™ – Non-Invasive Blood Glucose Alert Device at the Digital Health Exhibit at the International CES
Oxnard, Calif – (January 3, 2025) PreEvnt, a subsidiary of SCOSCHE Industries, a leading innovator of award-winning consumer technology will proudly unveil isaac* by PreEvnt at the Digital Health Exhibit at CES.
PreEvnt, A Subsidiary of Scosche Industries, To Introduce Their Revolutionary Non-Invasive Blood Glucose Alert Device at the 2025 International CES in Las Vegas
Oxnard, Calif – (December 17, 2024) PreEvnt, a subsidiary of SCOSCHE Industries, a leading innovator of award-winning consumer technology is pleased to announce the introduction of isaac* by PreEvnt to take place at the 2025 CES.
Media Coverage
Drug Delivery Business News
PreEvnt brings non-invasive gluclose alert device to clinical trials
November 24, 2025
Read More
AppleInsider
isaac by PreEvnt uses an iPhone app to track blood glucose with breath analysis
January 9, 2025
Read More
MediaPost - Marketing Daily
New Research, Plus CES Intros, Show Growth Of Wearables For Health
January 9, 2025
Read More
MacRumors
CES 2025 Day 2: Power Banks, Chargers, Hubs and Other Cool Apple Accessories
January 7, 2025
Read More
AndroidGuys
PreEvnt’s isaac Redefines Glucose Monitoring, One Breath at a Time
December 30, 2024
Read More
WhatsYourTech.ca
Consumer Electronics Show 2025: A Preview of What’s to Come in Tech
December 27, 2024
Read More